"10.1371_journal.pone.0048783","plos one","2012-11-08T00:00:00Z","Sarah Jesse; Stefan Lehnert; Olaf Jahn; Lucilla Parnetti; Hilkka Soininen; Sanna-Kaisa Herukka; Petra Steinacker; Saskia Tawfik; Hayrettin Tumani; Christine A F von Arnim; Manuela Neumann; Hans A Kretzschmar; Hasan Kulaksiz; Martin Lenter; Jens Wiltfang; Boris Ferger; Bastian Hengerer; Markus Otto","Department of Neurology, University of Ulm, Ulm, Germany; Proteomics Group, Max-Planck-Institute for Experimental Medicine, Goettingen, Germany; DFG Research Center for Molecular Physiology of the Brain, Goettingen, Germany; Department of Neurology, University of Perugia, Perugia, Italy; Department of Neurology, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland; Institute of Neuropathology, University of Zurich, Zurich, Switzerland; Institute of Neuropathology, Ludwig Maximilians University, Munich, Germany; Department of Internal Medicine, University of Ulm, Ulm, Germany; CNS Diseases Research, Boehringer Ingelheim GmbH & Co. KG, Biberach an der Riss, Germany; Department of Psychiatry, University of Essen-Duisburg, Essen-Duisburg, Germany","Conceived and designed the experiments: MO HT PS. Performed the experiments: SJ SL ST. Analyzed the data: OJ SJS SL. Contributed reagents/materials/analysis tools: LP HS SH CvA MN HAK HK ML JW BF BH. Wrote the paper: SJ SL MO.","The authors have the following interest: Martin Lenter, Boris Ferger and Bastian Hengerer are employed by CNS Diseases Research, Boehringer Ingelheim GmbH & Co. The rights of the study-data belong to the Landesstiftung Baden-Württemberg (P-LS-Prot/42)as a patent (482-36 US, Attorney Docket No.50818/002001 and 492-37, Attorney Docket No.50818/003001). There are no further products in development or marketed products to declare. This does not alter the authors‚ adherence to all the PLOS ONE policies on sharing data and materials.","2012","11","Sarah Jesse","SJ",18,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
